Teleflex Gets Canadian Approval for its Manta Vascular Closure Device

Teleflex has received Health Canada’s approval for its Manta vascular closure device, which is designed for large bore femoral arterial access site closure.

The Manta device is indicated for closure of arterial access sites while reducing time to hemostasis in endovascular catheterization procedures.

In a clinical trial, the device successfully achieved fast, reliable biomechanical closure and rapidly stopped the flow of blood, the company said, adding that more than 100,000 patients have been treated with Manta since its launch in 2016.

Wayne, Pa.-based Teleflex develops and manufactures devices for vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care.